Skip to main content
. 2023 Mar 6;308(3):935–940. doi: 10.1007/s00404-023-06938-5

Table 2.

(After Roerden [27]). Precautionary and emergency measures

Side effects Precautionary and emergency measures
systemic toxicity of local anesthetics (LAST) Termination of the TLA application
Oxygenation, treatment of seizures (benzodiazepine), resuscitation (if necessary), administration of 20% lipid emulsion
Continuous monitoring of vital parameters
Neurological symptoms (seizures, unconsciousness, restlessness) Termination of the TLA application
Oxygen supply, airway management, treatment of seizures (benzodiazepines), ECG monitoring if necessary
Apnea following cerebral toxicity Termination of the TLA application
Oxygen supply, resuscitation, continuous monitoring of vital parameters
Cardiovascular symptoms (bradycardia, hypotension, cardiac arrhythmias) Termination of the TLA application
Oxygenation, ECG monitoring
Treatment according to the ECG findings
Methemoglobinemia Termination of the TLA application
Oxygenation
Application of Methylene Blue
treatment of seizures (benzodiazepines)
Pneumothorax Use of non-ground needles in deep areas/ axilla
Application of TLA in the axilla under sonographic control
Continuous monitoring of vital parameters
Chest x-ray
Chest tube/ needle decompression if necessary